Every SEC Form 3/4/5 on record for this filer (CIK 1226690) — 1 issuer, 216 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| REGN | REGENERON PHARMACEUTICALS, INC. | Bd. Co-Chair, President & CSO · Director | 2015-11-03 → 2026-01-05 | 32 | −$399M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| REGN | 2024-05-16 | Sell | 4,886 | $976.52 | $5M | 787,989 |
| REGN | 2024-05-16 | Sell | 1,227 | $977.38 | $1M | 786,762 |
| REGN | 2024-05-16 | Sell | 379 | $978.18 | $370,730 | 786,383 |
| REGN | 2024-05-16 | Sell | 9,242 | $975.48 | $9M | 792,875 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.